Clinical Trial Update: Study of IMC-EB10 in Participant With Leukemia [Phase 1]

View source ↗

Summary

Phase 1 trial update for IMC-EB10 in participants with myeloid leukemia; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myeloid Leukemia

Drugs mentioned

• IMC-EB10

Snippet

Sponsor: Eli Lilly and Company | Conditions: Myeloid Leukemia | Phase 1 | Status: TERMINATED | Results posted: 2019-09-11